Quick answer
China SXT Pharmaceuticals (SXTC) fell 5.5% to $0.0650 on Friday, Oct 16, 2026, on 20.9x its 50-day average volume. There was no new SEC filing from the company in the five days up to the session, so the filing record does not explain the move.
Close (Oct 16, 2026)$0.0650
Change-5.5%
Volume vs 50-day avg20.9x
From 52-week high-100.0%
What the data shows about the move
- Industry peers (SPRC, LABT, ARTL) averaged -7.25%, suggesting the move was at least partly sector-wide.
- Volume of 263,853,000 shares was unusually heavy, which usually accompanies news, a filing or a financing.
SXTC move in numbers
| Metric | Value |
|---|---|
| Close | $0.0650 |
| Previous close | $0.0688 |
| Change ($) | -$0.0038 |
| Change (%) | -5.52% |
| Day high / low | $0.0818 / $0.0621 |
| Volume | 263,853,000 |
| 50-day average volume | 12,615,268 |
| 52-week high / low | $83,716.94 / $0.0619 |
| Above 52-week low | +5.0% |
| 50-day average price | $2.52 |
| 200-day average price | $786.25 |
Last 10 sessions
| Date | Close | Change | Volume |
|---|---|---|---|
| Oct 16, 2026 | $0.0650 | -5.52% | 263,853,000 |
| Oct 15, 2026 | $0.0688 | +0.44% | 62,492,710 |
| Oct 14, 2026 | $0.0685 | -11.50% | 33,510,810 |
| Oct 13, 2026 | $0.0774 | -24.12% | 59,630,890 |
| Oct 12, 2026 | $0.1020 | -31.41% | 82,690,800 |
| Oct 9, 2026 | $0.1487 | -56.71% | 116,276,100 |
| Oct 8, 2026 | $0.3435 | -87.86% | 64,912,360 |
| Oct 7, 2026 | $2.83 | +126.40% | 146,566,900 |
| Oct 6, 2026 | $1.25 | -39.90% | 9,547,109 |
| Oct 5, 2026 | $2.08 | -13.69% | 950,463 |
Peers in Biotechnology: Pharmaceutical Preparations
| Company | Close Oct 16, 2026 | Change |
|---|---|---|
| SPRC SciSparc | $1.70 | -15.00% |
| LABT Lakewood-Amedex Biotherapeutics | $0.5800 | -5.29% |
| ARTL Artelo Biosciences | $2.70 | -1.46% |
Bull vs bear points from the data
Bull points
- None stand out in the price data.
Bear points
- Closed below its 50-day average price ($2.52).
- Below its 200-day average ($786.25), the long-term trend line.
- Still 100.0% below its 52-week high of $83,716.94.
- Only 5.0% above its 52-week low of $0.0619.
- The drop came on 20.9x normal volume, a sign of conviction behind the move.
- Down 56.3% over the last five sessions.
Points are computed from price, volume and filing data only; they are not forecasts or recommendations.
Latest SEC filings for SXTC
| Form | Filed | Detail | Link |
|---|---|---|---|
| 6-K | Oct 9, 2026 | REPORT OF FOREIGN PRIVATE ISSUER | EDGAR |
| 424B5 | Oct 9, 2026 | PROSPECTUS SUPPLEMENT | EDGAR |
| 6-K | Oct 8, 2026 | REPORT OF FOREIGN PRIVATE ISSUER | EDGAR |
| 6-K | Oct 8, 2026 | REPORT OF FOREIGN PRIVATE ISSUER | EDGAR |
| 6-K | Aug 28, 2026 | REPORT OF FOREIGN PRIVATE ISSUER | EDGAR |
| 6-K | Jul 24, 2026 | REPORT OF FOREIGN PRIVATE ISSUER | EDGAR |
For the full picture, including financials from SEC filings and insider trades, see our SXTC stock analysis.
Sources
- SEC EDGAR: China SXT Pharmaceuticals Form 6-K filing index (filed Oct 9, 2026)
- SEC EDGAR: China SXT Pharmaceuticals Form 424B5 filing index (filed Oct 9, 2026)
- SEC EDGAR: China SXT Pharmaceuticals Form 6-K filing index (filed Oct 8, 2026)
- SEC EDGAR: China SXT Pharmaceuticals Form 6-K filing index (filed Oct 8, 2026)
- SEC EDGAR: China SXT Pharmaceuticals Form 6-K filing index (filed Aug 28, 2026)
- SEC EDGAR: China SXT Pharmaceuticals Form 6-K filing index (filed Jul 24, 2026)
- Nasdaq: SXTC historical prices and volume (daily data through Oct 16, 2026 close, retrieved Oct 19, 2026)
- Nasdaq: SPRC historical prices (peer) (Oct 16, 2026 close)
- Nasdaq: LABT historical prices (peer) (Oct 16, 2026 close)
- Nasdaq: ARTL historical prices (peer) (Oct 16, 2026 close)
- Nasdaq: SXTC earnings date (retrieved Oct 19, 2026)